Twist Bioscience (TWST) Total Current Liabilities (2018 - 2026)

Twist Bioscience (TWST) has 9 years of Total Current Liabilities data on file, last reported at $120.0 million in Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $120.0 million, up 60.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $120.0 million (up 60.02% YoY), and the FY2025 annual result was $91.4 million, up 28.73% from the prior year.
• Total Current Liabilities grew to $120.0 million in Q1 2026 per TWST's latest filing, from $80.4 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $120.0 million in Q1 2026 and troughed at $65.2 million in Q4 2023.
• A 5-year average of $80.7 million and a median of $75.0 million in 2025 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2022 and 2023: Total Current Liabilities soared 109.27% in 2022, then decreased 22.2% in 2023.
• A 5-year view of Total Current Liabilities shows it stood at $83.8 million in 2022, then fell by 22.2% to $65.2 million in 2023, then grew by 6.77% to $69.6 million in 2024, then advanced by 15.5% to $80.4 million in 2025, then surged by 49.15% to $120.0 million in 2026.
• Business Quant data shows TWST's Total Current Liabilities at $120.0 million in Q1 2026, $80.4 million in Q4 2025, and $91.4 million in Q3 2025.